Disease Info Card

Granuloma, Plasma Cell

Information about Granuloma, Plasma Cell: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Granuloma, Plasma Cell

Most recent studies have shown that Granuloma, Plasma Cell shares some biological mechanisms with carcinoma, fibrosis, granuloma, inflammation, inflammatory-myofibroblastic-tumor, liver-diseases, liver-inflammatory-myofibroblastic-tumor, liver-neoplasms, lung-diseases, lung-neoplasms, lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasms, pain, pseudotumor, sarcoma, splenic-diseases, urinary-bladder-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Granuloma, Plasma Cell, and have been seen in publications frequently: Aging, Cell Growth, Cell Proliferation, Chronic Inflammatory Response, Coagulation, Cytokine Production, Germinal Center Formation, Granuloma Formation, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Metaphase, Mitosis, Ossification, Pathogenesis, Response To Radiation, Transport, Transposition

Quite a number of genes have been found to play important roles in Granuloma, Plasma Cell, such as ACVRL1, ALK, CD34, CD68, CR1, CR2, CRP, CTLA4, DES, HLA-DQA1, IL6, KRT20, NOD2, S100A1, S100B, TRIT1, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.